156 related articles for article (PubMed ID: 26372651)
1. Phenothiazine-based CaaX competitive inhibitors of human farnesyltransferase bearing a cysteine, methionine, serine or valine moiety as a new family of antitumoral compounds.
Dumitriu GM; Bîcu E; Belei D; Rigo B; Dubois J; Farce A; Ghinet A
Bioorg Med Chem Lett; 2015 Oct; 25(20):4447-52. PubMed ID: 26372651
[TBL] [Abstract][Full Text] [Related]
2. Peptide chemistry applied to a new family of phenothiazine-containing inhibitors of human farnesyltransferase.
Dumitriu GM; Ghinet A; Bîcu E; Rigo B; Dubois J; Farce A; Belei D
Bioorg Med Chem Lett; 2014 Jul; 24(14):3180-5. PubMed ID: 24856060
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of a new series of phenothiazine-containing protein farnesyltransferase inhibitors.
Abuhaie CM; Ghinet A; Farce A; Dubois J; Gautret P; Rigo B; Belei D; Bîcu E
Eur J Med Chem; 2013 Jan; 59():101-10. PubMed ID: 23207411
[TBL] [Abstract][Full Text] [Related]
4. New farnesyltransferase inhibitors in the phenothiazine series.
Belei D; Dumea C; Samson A; Farce A; Dubois J; Bîcu E; Ghinet A
Bioorg Med Chem Lett; 2012 Jul; 22(14):4517-22. PubMed ID: 22738631
[TBL] [Abstract][Full Text] [Related]
5. Indolizine-phenothiazine hybrids as the first dual inhibitors of tubulin polymerization and farnesyltransferase with synergistic antitumor activity.
Moise IM; Bîcu E; Farce A; Dubois J; Ghinet A
Bioorg Chem; 2020 Oct; 103():104184. PubMed ID: 32891861
[TBL] [Abstract][Full Text] [Related]
6. New indolizine-chalcones as potent inhibitors of human farnesyltransferase: Design, synthesis and biological evaluation.
Moise IM; Ghinet A; Belei D; Dubois J; Farce A; Bîcu E
Bioorg Med Chem Lett; 2016 Aug; 26(15):3730-4. PubMed ID: 27282741
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of a new series of N-ylides as protein farnesyltransferase inhibitors.
Abuhaie CM; Ghinet A; Farce A; Dubois J; Rigo B; Bîcu E
Bioorg Med Chem Lett; 2013 Nov; 23(21):5887-92. PubMed ID: 24054122
[TBL] [Abstract][Full Text] [Related]
8. Novel conformationally extended naphthalene-based inhibitors of farnesyltransferase.
Burns CJ; Guitton JD; Baudoin B; Lelièvre Y; Duchesne M; Parker F; Fromage N; Commerçon A
J Med Chem; 1997 Jun; 40(12):1763-7. PubMed ID: 9191950
[No Abstract] [Full Text] [Related]
9. Synthesis and biological evaluation of new phenothiazine derivatives bearing a pyrazole unit as protein farnesyltransferase inhibitors.
Baciu-Atudosie L; Ghinet A; Farce A; Dubois J; Belei D; Bîcu E
Bioorg Med Chem Lett; 2012 Nov; 22(22):6896-902. PubMed ID: 23036952
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and characterization of piperazinedione-based dual protein inhibitors for both farnesyltransferase and geranylgeranyltransferase-I.
Qiao Y; Gao J; Qiu Y; Wu L; Guo F; Lo KK; Li D
Eur J Med Chem; 2011 Jun; 46(6):2264-73. PubMed ID: 21440964
[TBL] [Abstract][Full Text] [Related]
11. Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activity.
Leftheris K; Kline T; Vite GD; Cho YH; Bhide RS; Patel DV; Patel MM; Schmidt RJ; Weller HN; Andahazy ML; Carboni JM; Gullo-Brown JL; Lee FY; Ricca C; Rose WC; Yan N; Barbacid M; Hunt JT; Meyers CA; Seizinger BR; Zahler R; Manne V
J Med Chem; 1996 Jan; 39(1):224-36. PubMed ID: 8568812
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of homofarnesoyl-substituted CAAX-peptidomimetics as farnesyltransferase inhibitors and antiproliferative agents.
Schlitzer M; Sattler I; Dahse HM
Bioorg Med Chem; 1999 Sep; 7(9):2037-45. PubMed ID: 10530953
[TBL] [Abstract][Full Text] [Related]
13. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
[TBL] [Abstract][Full Text] [Related]
14. A novel inhibitor of farnesyltransferase with a zinc site recognition moiety and a farnesyl group.
Tanaka A; Radwan MO; Hamasaki A; Ejima A; Obata E; Koga R; Tateishi H; Okamoto Y; Fujita M; Nakao M; Umezawa K; Tamanoi F; Otsuka M
Bioorg Med Chem Lett; 2017 Aug; 27(16):3862-3866. PubMed ID: 28666734
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, molecular modeling, and structure-activity relationship of benzophenone-based CAAX-peptidomimetic farnesyltransferase inhibitors.
Sakowski J; Böhm M; Sattler I; Dahse HM; Schlitzer M
J Med Chem; 2001 Aug; 44(18):2886-99. PubMed ID: 11520197
[TBL] [Abstract][Full Text] [Related]
16. Farnesyltransferase inhibitors: CAAX mimetics based on different biaryl scaffolds.
Straniero V; Pallavicini M; Chiodini G; Ruggeri P; Fumagalli L; Bolchi C; Corsini A; Ferri N; Ricci C; Valoti E
Bioorg Med Chem Lett; 2014 Jul; 24(13):2924-7. PubMed ID: 24821376
[TBL] [Abstract][Full Text] [Related]
17. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
[TBL] [Abstract][Full Text] [Related]
18. Thiazole- and imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase.
Bolchi C; Pallavicini M; Bernini SK; Chiodini G; Corsini A; Ferri N; Fumagalli L; Straniero V; Valoti E
Bioorg Med Chem Lett; 2011 Sep; 21(18):5408-12. PubMed ID: 21802946
[TBL] [Abstract][Full Text] [Related]
19. Exploring isoxazoles and pyrrolidinones decorated with the 4,6-dimethoxy-1,3,5-triazine unit as human farnesyltransferase inhibitors.
Lucescu L; Ghinet A; Shova S; Magnez R; Thuru X; Farce A; Rigo B; Belei D; Dubois J; Bîcu E
Arch Pharm (Weinheim); 2019 May; 352(5):e1800227. PubMed ID: 30947375
[TBL] [Abstract][Full Text] [Related]
20. Impact on farnesyltransferase inhibition of 4-chlorophenyl moiety replacement in the Zarnestra series.
Angibaud P; Mevellec L; Meyer C; Bourdrez X; Lezouret P; Pilatte I; Poncelet V; Roux B; Merillon S; End DW; Van Dun J; Wouters W; Venet M
Eur J Med Chem; 2007 May; 42(5):702-14. PubMed ID: 17316920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
